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Abstract
 
Both innate and adaptive immune responses are dependent on activation of nuclear factor 
 
 
 
B
(NF-
 
 
 
B), induced upon binding of pathogen-associated molecular patterns to Toll-like receptors
(TLRs). In murine models, defects in NF-
 
 
 
B pathway are often lethal and viable knockout
mice have severe immune defects. Similarly, defects in the human NF-
 
 
 
B pathway described
to date lead to severe clinical disease. Here, we describe a patient with a hyper immunoglobulin
M–like immunodeficiency syndrome and ectodermal dysplasia. Monocytes did not produce
interleukin 12p40 upon stimulation with various TLR stimuli and nuclear translocation of
NF-
 
 
 
B was impaired. T cell receptor–mediated proliferation was also impaired. A heterozygous
mutation was found at serine 32 in I
 
 
 
B
 
 
 
. Interestingly, his father has the same mutation but
displays complex mosaicism. He does not display features of ectodermal dysplasia and did not
suffer from serious infections with the exception of a relapsing 
 
Salmonella typhimurium
 
 infection.
His monocyte function was impaired, whereas T cell function was relatively normal. Consis-
tent with this, his T cells almost exclusively displayed the wild-type allele, whereas both alleles
were present in his monocytes. We propose that the T and B cell compartment of the mosaic
father arose as a result of selection of wild-type cells and that this underlies the widely different
clinical phenotype.
Key words: immunodeﬁciency • I
 
 
 
B
 
 
 
 • monocyte function • T cell activation • infection
 
Introduction
 
Recognition of pathogen-associated molecular patterns
(PAMPs) via Toll-like receptors (TLRs) is a crucial step in
the human defense. Both innate and adaptive immune re-
sponses are thought to be highly dependent on signal trans-
duction induced upon ligation of such receptors, and it is
now well established that mice that lack specific TLRs, or
components necessary for TLR-mediated signal transduction,
are highly susceptible to specific pathogens. For instance,
mice deficient for TLR4, which is important for recognition
of LPS, a component of the cell wall of Gram-negative
bacteria, are very susceptible to infection by 
 
Salmonella
 
 (1),
whereas susceptibility to 
 
Mycobacterium avium
 
 (2) or 
 
Toxoplasma
gondii
 
 (3) infection is not affected. Mice deficient for
TLR2, which is important for the recognition of cell wall
components of Gram-positive bacteria, are susceptible to
infection with 
 
Staphylococcus aureus
 
 (4) or 
 
M. avium
 
 (2). On
the other hand, MyD88-defective mice, which lack a com-
mon signaling protein involved in signal transduction via
several TLRs, are highly susceptible to virtually every patho-
gen tested (2, 4–6), indicating the importance of recognition
of PAMPs in combating a wide range of infections.
Upon ligation of TLRs, signal transduction is initiated,
resulting in the activation of MAP kinases and NF-
 
 
 
B (for
review see reference 7), the latter one being responsible for
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the induction of proinflammatory cytokine production. In
resting cells, the inhibitor of NF-
 
 
 
B, I
 
 
 
B, associates with
NF-
 
 
 
B, thereby inhibiting its nuclear translocation and the
transcription of NF-
 
 
 
B–responsive genes. In response to
TLR ligation, I
 
 
 
B is phosphorylated through the action of
the I
 
 
 
B kinase (IKK) complex (consisting of IKK
 
 
 
, IKK
 
 
 
,
and NEMO) and subsequently ubiquitinated and degraded
by the proteasome, allowing translocation of NF-
 
 
 
B to the
nucleus (for review see reference 8). Patients with various
defects in PAMP-induced signal transduction have been de-
scribed. For instance, patients with defects in NEMO, the
regulatory subunit of the IKK complex that phosphorylates
I
 
 
 
B, suffer from a broad clinical spectrum of disease includ-
ing ectodermal dysplasia, high IgM, and susceptibility to a
broad range of infectious agents (9). Recently, defects in
IRAK4, one of the proteins upstream of IKK-dependent
I
 
 
 
B phosphorylation, have been reported (10, 11). The four
patients described to date suffered from pyogenic infections.
In murine models, defects in the NF-
 
 
 
B signaling path-
way are often lethal, and knockout mice that are viable
have severe defects in immune cell function, highlighting
the importance of this signal transduction pathway in mice
(for review see references 8 and 12). Similarly, defects in
the human NF-
 
 
 
B pathway that have been described to
date all lead to a relatively severe clinical syndrome (10, 11,
13), suggesting that optimal signal transduction via this
pathway is also crucial in humans. However, because case
finding is biased toward the identification of patients with
severe symptoms, the true importance of this signal trans-
duction pathway in the development of human disease is
not known. Here, we describe a patient with a hyper IgM-
like immunodeficiency syndrome with ectodermal dyspla-
sia. Both T cell and monocyte function were severely
impaired in this patient, and we found the mutation re-
sponsible for this syndrome in the I
 
 
 
B
 
  
 
gene. Interestingly,
his father, who has the same mutation, does not display ec-
todermal dysplasia nor severe infection susceptibility. These
cases illustrate that genetic mutations in components of the
NF-
 
 
 
B signaling pathway do not necessarily lead to a life-
threatening clinical phenotype.
 
Materials and Methods
 
Case Reports.
 
A male infant was born as the first child to non-
consanguineous Caucasian parents after an uncomplicated preg-
nancy of 39
 
 
 
3 
 
wk. At birth, his weight and length were 3,175 g
(SD 
 
 
 
1) and 49 cm (SD 
 
 
 
1), respectively. Physical examination
at birth revealed no abnormalities. Other than mild cutaneous
candidiasis, there were no major complications during the first 2
mo of life. At the age of 2 mo, he presented with clinical signs of
meningitis. 
 
 
 
-hemolytic group A streptococcus was cultured from
the cerebrospinal fluid. He made a rapid and complete recovery
after treatment with parenteral antibiotics. However, a persistent
leukocytosis was present during follow-up (20–35 
 
  
 
10e9/L)
with a polyclonal lymphocytosis of 55–80%. At the age of 4 mo,
he presented with fever and dyspnea. Chest X ray revealed an in-
terstitial infiltrate compatible with a diagnosis of pneumonia. A
 
 
 
-hemolytic group A streptococcus was isolated again from blood
cultures. This time, clinical improvement was only moderate after
antibiotic treatment, and he remained tachypneic and required
continuation of oxygen. In bronchoalveolar lavage fluid, 
 
Pneu-
mocystis carinii
 
 was identified. The patient recovered rapidly during
treatment with high dose cotrimoxazole. Subsequent immunolog-
ical evaluation revealed an agammaglobulinemia (0.5 g/L; see Ta-
ble I) with a strongly increased serum IgM. Again, leukocytosis
persisted after recovery from the infection. The lymphocytosis
predominated with a CD4/CD8 ratio of 2.1–2.8:1 and was almost
exclusively composed of naive (CD45RA
 
 
 
) T lymphocytes. Hy-
per IgM syndrome was considered, but CD154 was expressed
normally on activated T lymphocytes. Sequence analysis of the
CD154, CD40, AID, and NEMO genes revealed no mutations
(not depicted). Sequencing analysis of IGG and IGA transcripts
showed that somatic hypermutations were present, although in
low frequencies (
 
 
 
2%; not depicted). Immunological findings of
the patient and his parents are summarized in Table I. Based on
chromosomal studies, we could exclude ataxia telangiectasia, Nij-
megen breakage syndrome, and ICF syndrome (not depicted).
From the second infection onwards, Ig substitution was initiated
together with cotrimoxazole as 
 
P. carinii
 
 prophylaxis. Except for
intermittently recurrent mucosal candidiasis that responded to flu-
conazole, no subsequent serious infections were encountered dur-
ing follow-up. At the age of 2 yr, the patient was vaccinated with
tetanus toxoid (TT) and diphtheria toxoid, inactivated poliovirus,
and 
 
Haemophilus influenzae
 
 conjugate, and was boosted twice. No
seroconversion was documented for all of the antigens tested (not
depicted). After the first months of life, several signs of ectodermal
dysplasia became manifest and comprised abnormal dentition (typ-
ical conical teeth) and periorbital wrinkling. During the first 2 yr
of life, a retardation in neuromotor development became obvious,
characterized by a delay in speech development and the inability
to walk. A growth retardation became evident after the first 6 mo,
starting at 
 
 
 
1 SD and declining below 
 
 
 
2 SD at the age of two.
The latter two phenomena are not common features of ectoder-
mal dysplasia syndromes. In addition, he developed periodic diar-
rhea and oral feeding was less well tolerated. Stool analysis for bac-
terial, viral, and parasitic infections by culture and microscopy
remained negative. During his second year he became dependent
on nasogastric hyper-alimenation. At the age of 2.5 yr, the boy
was scheduled for allogeneic stem cell transplantation, which will
be described separately.
The patients’ father was born from nonconsanguineous Cau-
casian parents. At the age of two, he presented with arthritis of
the knee that resolved spontaneously. After a disease-free interval
of 6 yr, he developed fever, a typical rash, and arthritis. Systemic
juvenile idiopathic arthritis (JIA) was diagnosed and steroid treat-
ment was initiated and continued until the age of 17. After a
therapy-free interval of 
 
 
 
2 yr, he developed a 
 
Salmonella typhimu-
rium
 
 enteritis that was treated with chloramphenicol. During the
next 1.5 yr, the 
 
S. typhimurium
 
 infection persisted with recurrent
manifestations in psoas muscle, pleural cavity, pericardial fluid,
and ribs. 10 yr ago, two ribs and preural schwarte were resected.
The infection finally resolved after prolonged treatment with cot-
rimoxazole and amoxicillin. After a 7-yr, symptom-free interval,
he developed rheumatoid factor–positive oligoarthritis, which re-
solved upon treatment with nonsteroid antiinflammatory drugs.
Presently, he has no health complaints and is not taking any med-
ication. Serum Ig levels and lymphocyte counts are within the
normal range and a normal ratio between naive and memory T
lymphocytes is present (see Table I).
 
Isolation of PBMCs and Culture of Human Monocyte–derived Mac-
rophages.
 
PBMCs were isolated from heparinized blood using
density centrifugation over a Ficoll-Hypaque gradient (Amer- 
Janssen et al.
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sham Biosciences). For generation of macrophages, PBMCs were
cultured in 6-well tissue culture plates (Costar) in Dulbecco’s
modified Eagle’s medium (GIBCO BRL) supplemented with 2
mM 
 
l
 
-glutamine, 100 U/ml penicillin, 0.1 mg/ml streptomycin,
and 10% heat-inactivated pooled human serum. After 24 h, non-
adherent cells were removed by extensive washing and cells were
cultured for 6 d to obtain monocyte-derived macrophages. Cells
were trypsinized and adhered onto glass coverslips, and then cul-
tured for another 2–3 d. Any remaining nonadherent cells were
washed away, and relatively pure (
 
 
 
95%) monocyte-derived
macrophage populations were obtained.
 
Lymphocyte Proliferation.
 
Triplicate cultures of 0.4 
 
  
 
10
 
5
 
PBMCs or 0.2 
 
  
 
10
 
5 
 
CD20
 
  
 
B cells per well in medium (RPMI
1640 glutamax 1 [GIBCO BRL] supplemented with 10%
heat-inactivated pooled human AB serum, 100 U/ml penicillin
[GIBCO BRL], and 100 
 
 
 
g/ml streptomycin [GIBCO BRL])
were performed in 96-well, flat-bottom microtitre plates (Costar)
using 5 
 
 
 
g/ml PHA (Murex), 50 IU/ml IL-2 (Chiron Corp.),
500 ng/ml anti-CD40 (Beckman Coulter), 500 U/ml IL-4 (Pep-
roTech), and coated anti-CD3 (0.1 
 
 
 
g/ml OKT3 in PBS; Ortho
Clinical Diagnostics) as stimuli.
After 4 d of culture, 1 
 
 
 
Ci/well [
 
3
 
H]thymidine (Amersham
Biosciences) was added 18 h before harvesting. [
 
3
 
H]thymidine
uptake of cultured PBMCs was measured as cpm by liquid scin-
tillation counter (Wallac). Triplicate cultures of 10
 
5 
 
PBMCs per
well were performed in 96-well, round-bottom microtitre plates
(Costar) in medium. Cells were cultured for 5 d with 2 LF/ml
TT (RIVM) followed by the addition of [
 
3
 
H]thymidine as de-
scribed above. Results are shown as a stimulation index (ratio
mean cpm TT/mean cpm medium). A stimulation index of 
 
 
 
3.0
was considered evidence of antigen-induced proliferation.
 
Immunophenotyping and Sorting of Lymphocytes.
 
PBMCs were
phenotyped by four color immunostaining using FITC-, PE-,
PerCPCy5.5-, and APC-conjugated antibodies, and analyzed by
flow cytometry (FACSCalibur; Becton Dickinson). Data were an-
alyzed using CELLQuest software (Becton Dickinson). Cell sorting
was performed on a FACS Vantage (Becton Dickinson).
 
Stimulation of Whole Blood.
 
Blood collected in endotoxin-
free tubes (Endotube ET; Chromogenix) was diluted 1 in 5 and
stimulated overnight with 0.1–1,000 ng/ml LPS in the presence
or absence of 10–1,000 IU IFN-
 
 
 
/ml. Other TLR stimuli used
were 25 
 
 
 
g/ml 
 
M. avium
 
 sonicate, 100 
 
 
 
g/ml zymosan A, 
 
S.
aureus
 
 (5 
 
  
 
10
 
6 
 
heat-killed bacteria/ml), and 200 ng/ml
PAM3CSK4. Supernatants were tested by ELISA for the pres-
ence of IL-12p40 (R&D Systems), IL-6, IL-1
 
 
 
, and TNF-
 
 
 
(Sanquin Research).
 
IFN-
 
  
 
Responsiveness of Monocytes.
 
PBMCs were incubated
overnight with increasing amounts of IFN-
 
  
 
(0–100 IU/ml) in
hydron-coated wells to prevent adherence of the monocytes.
Cells were washed and stained with FITC-conjugated anti-CD64
and PE-conjugated anti-CD14 to analyze CD64 expression on
CD14
 
  
 
cells using a FACSCalibur.
 
Oxidative Burst.
 
PMNs were isolated from whole blood by
centrifugation over a Ficoll-Hypaque gradient (Amersham Bio-
sciences). Red blood cells in the pellets were lysed using 180 mM
NH4Cl for 20 min. Neutrophils were incubated with 5 
 
 
 
g/ml
LPS or 200 ng/ml TNF-
 
  
 
for 30 min. After the addition of 10
 
 
 
M DCF-DA, cells were incubated with 1 
 
 
 
M formyl-methio-
nyl-leucyl-phenylalanine for 5 min and fluorescence was mea-
sured by FACS analysis.
 
NF-
 
 
 
B Translocation to the Nucleus.
 
Monocyte-derived mac-
rophages cultured on glass coverslips were incubated with 1,000
ng/ml LPS or 200 ng/ml TNF-  for 45 min, and p65 transloca-
tion to the nucleus was analyzed (14). Cells were fixed with para-
formaldehyde and permeabilized with methanol. Cells were
stained with a p65-specific antibody (SC-109; Santa Cruz Bio-
technology, Inc.) and a Rhodamine RedX–conjugated goat anti–
rabbit antibody (Jackson ImmunoResearch Laboratories) was
added. Nuclei were stained with DAPI and coverslips were ana-
lyzed by fluorescence microscopy. Translocation of p65 to the
nucleus was scored by enumerating the number of cells that had
no nuclear staining ( ), cells that displayed both cytoplasmic and
nuclear staining ( ), or cells that displayed bright nuclear staining
and hardly any cytoplasmic staining ( ).
DNA Manipulations and Sequence Analysis. Genomic DNA
and total RNA were isolated from whole blood and the 5  region
of the IKBA gene and the promoter region were amplified by
PCR using the primers described elsewhere (13, 15). Sequence
analysis was performed using a Capillary Sequencer ABI 3700.
For determination of wild-type versus mutated allele, PCR prod-
ucts generated using cDNA or genomic DNA as a template were
digested with MspAI, which only digests the wild-type allele. In
addition, the silent polymorphism in the father was determined
by digestion with FokI, which only digests the polymorphic al-
lele. Three different dilutions of the digested products were ana-
lyzed on a 2% agarose gel. The ratio of wild-type versus mutant
allele in father and son were semiquantified by measuring the in-
tensity of the undigested and digested band densitometrically, us-
ing a Gel Doc 2000 system (BioRad Laboratories) and Quantity
One software (Bio-Rad Laboratories). To account for the size
difference between the digested and undigested bands, the diges-
tion efficiency of the two restriction enzymes, and possible exo-
nuclease activity in the two restriction enzymes, ratios were cor-
rected using an experimentally determined correction factor. For
MspAI digests, which discriminate between wild-type and mu-
tant alleles, this correction factor was obtained by setting the av-
erage intensity ratio found with genomic DNA of all cell types of
the son, a true heterozygote, to 1, resulting in a correction factor
of 3.7. The values for his mRNA and genomic DNA and
mRNA of the father were corrected accordingly. A correction
factor for FokI digests, which discriminate between the polymor-
phic and nonpolymorphic allele, was determined setting the aver-
age intensity ratio, obtained with DNA of the four other family
members who are heterozygous for this polymorphism, to 1, re-
sulting in a correction factor of 1.46. All other ratios were cor-
rected using this factor.
Results
T and B Cell Function in the Patient. The patient pre-
sented with very high IgM levels, virtually no detectable
IgG, and severe infection susceptibility. The other remark-
able feature was a persistent lymphocytosis composed of
CD4 and CD8 T cells at a normal ratio and virtually all ex-
pressing    TCRs. Further analysis revealed that  95% of
both T cell subsets displayed a naive phenotype (i.e.,
CD45RA  [Table I], CD27 , CD28 , and CCR7  [not
depicted]), indicating a maturation block. Flow cytometric
and molecular analysis of the peripheral T cell compartment
revealed a polyclonal V  repertoire (not depicted). Subnor-
mal numbers of NK and B cells were present. In contrast,
normal numbers of T and B lymphocytes and NK cells as
well as normal serum Ig levels were present in both parents
(Table I). Phenotypical analysis revealed relatively lowOne I B  Mutation: Two Phenotypes 562
numbers of naive CD4 and CD8 T cells in the father. In ad-
dition, an increased number of    T lymphocytes were de-
tected in the father. To determine T cell function, prolifera-
tive responses were measured after stimulation with various
polyclonal activators and TT. Stimulation via TCR ligation
by anti-CD3 mAbs or with PHA resulted in strongly im-
paired responses (Table II). These decreased responses could
be partly overcome by additional costimulation with IL-2.
Antigen-specific proliferation that was analyzed after three
repetitive vaccinations with TT was completely absent. The
proliferative response of the paternal T cells after stimulation
with anti-CD3 was also impaired, albeit to a much lesser
extent than in the child. The proliferative responses of the
maternal T cells were unaffected. B cell proliferative re-
sponses were tested after stimulation with anti-CD40 and
IL-4. Normal proliferative responses were measured in both
the child and father (Table II). 
IL-12p40 Production in Response to LPS. Monocyte
function of the affected child and his parents was deter-
mined by culturing whole blood in the presence of increas-
ing amounts of LPS. IL-12p40 production was completely
absent in the child and, even at LPS concentrations up to
1,000 ng/ml, also hardly detectable in his father, whereas
his mother and a control produced normal amounts of this
cytokine (Fig. 1 A, black bars). This indicated that IL-
12p40 production in response to LPS was not only im-
paired in the patient, but also in his father, who displays a
completely different clinical phenotype.
To investigate whether IL-12p40 production could be
induced when other TLR4 or TLR2 stimuli were used,
whole blood was stimulated with M. avium, zymosan A, S.
aureus, or PAM3CSK4. In contrast to the healthy control or
the mother, none of the stimuli were able to induce signifi-
cant amounts of IL-12p40 in father and son, indicating that
a possible defect was downstream of the TLRs (Fig. 1 B).
To investigate whether IL-12p40 production could be
up-regulated by IFN- , the combination of LPS and a high
dose of IFN-  (1,000 IU/ml) was used to stimulate whole
Table I. Phenotype and Absolute Numbers of Blood Cells and Serum Ig Levels of the Patient, His Parents, and Controls
Patient
(22 mo) Father Mother
Normal
(15–24 mo)
Normal
(adult)
Blood cells ( 109 L)
Leukocytes 18.1 5.3 10.2 6.8–10.0 4.3–10.0
Lymphocytes 14.3 1.6 1.7 2.7–11.9 1.0–2.8
Monocytes 1.4 0.9 0.9 unknown 0.2–1
T cells 13.6 1.1 1.3 1.4–8.0 0.7–2.1
   T cells   0.1 0.5  0.1
CD4  T cells 9.9 0.5 0.7 0.9–5.5 0.3–1.4
Naive (CD45RA) 9.5 0.1 0.3 1.1–3.6 0.2–0.9
Activated (CD45RO) 0.5 0.3 0.4 0.2–0.7 0.2–1
CD8  T cells 3.7 0.2 0.6 0.4–2.3 0.2–0.9
Naive (CD45RA) 3.7  0.1 0.3 0.6–1.8 0.1–0.7
Activated (CD45RO) 0.1 0.1 0.3  0.1–1  0.1–0.5
B cells (CD19  CD20 ) 0.4 0.3 0.2 0.6–3.1 0.1–0.5
Serum Ig levels
IgM (g/liter) 14.6 0.5 0.8 0.4–2.3 0.4–2.6
IgG (g/liter) 5.2a 14.6 9.9 3.5–11.4 6.6–18.4
IgA (g/liter)  0.06 2.1 1.3 0.1–1.0 0.71–3.6
IgD (g/liter) 0.9 n.d. n.d.  0.2
aAfter intravenous IgG supplementation, the IgG level was 0.5 g/liter before therapy.
n.d., not done.
Figure 1. Production of IL-12p40 in whole blood of a healthy control,
the mother, the father, and the child. (A) Whole blood was stimulated with
LPS in the presence or absence of IFN- . (B) Whole blood was stimulated
with 25  g/ml M. avium sonicate, 100  g/ml zymosan A, S. aureus (5  
106 heat-killed bacteria/ml), and 200 ng/ml PAM3CSK4. Supernatants
were collected after 18 h and IL-12p40 was measured by ELISA.Janssen et al. 563
blood. In the child, IL-12p40 was still not detectable, but
his father produced some IL-12p40, although the levels
were very low (Fig. 1 A, white bars). This was confirmed
at the level of mRNA production (not depicted).
Secretion of Other Cytokines in Whole Blood. Synthesis of
IL-12p40 is dependent on NF- B–activated transcription,
suggesting that a possible defect was located in the NF- B
signal transduction pathway. Therefore, we also measured
other cytokines that are induced upon NF- B activation.
Upon stimulation of whole blood with a high concentra-
tion of LPS, TNF-  and IL-1  production in the child
were comparable to that of his father, mother, and the con-
trol (Fig. 2, A and C, black bars). On the other hand, IL-6
production was very low in the child but completely nor-
mal in his father (Fig. 2 B). These results indicate that not
all of the NF- B–dependent responses are impaired and
that the functional defect in the child’s monocytes was
more severe than that in his father.
Another striking observation was that IFN-  was not
able to enhance TNF-  production in either father or son,
whereas the mother and a healthy control up-regulated
TNF-  production in the presence of IFN-  (Fig. 2 A,
white bars). This indicates that a possible defect in father
and son results in impaired LPS responsiveness as well as
impaired IFN-  responsiveness of whole blood cells. It is
important to note that IFN-  concentrations up to 1,000
IU/ml were used in our assays, highlighting the true extent
of IFN-  unresponsiveness. IFN- R expression was nor-
mal (not depicted).
IFN-  Responsiveness Is Normal in Patient’s PBMCs. To
study the response to IFN-   in more detail, monocytes
were cultured in the presence of IFN-  and the increase in
expression of CD64 (Fc R1) was measured by FACS anal-
ysis. The CD64 promoter contains a STAT1 binding site
and up-regulation of CD64 in response to IFN-  stimula-
tion is a well-accepted marker of IFN-  responsiveness of
cells. IFN-  stimulation of control monocytes and those of
the mother resulted in a dose-dependent increase in CD64
expression (Fig. 3). A dose-dependent increase was also seen
in monocytes of father and son, although the maximal in-
Table II. T Cell Responses of the Patient and His Parents
Cultured cells Stimulus Patient Father Mother
PBMCs anti-CD3 0.3 59.5 350.1
anti-CD3   IL-2 15.5 155.0 433.5
PHA 23.8 130.5 293.0
PHA   IL-2 299.0 213.7 334.4
none  0.2  0.2  0.2
TT
preimmunizationa 1 8.5 n.d.
TT
6 wk after three immunizationsa 1 n.d. n.d.
CD20  B cells anti-CD40   IL-4 3.6 1.5 n.d.
none  0.05  0.05 n.d.
Data are presented as cpm   103 or aas stimulation index.
n.d., not done.
Figure 2. Production of other cy-
tokines in whole blood. Whole
blood was stimulated with LPS (A,
B, and C) in the presence or absence
of IFN-   (A). Supernatants were
collected after 18 h and TNF-  (A),
IL-6 (B), and IL-1  (C) was mea-
sured by ELISA.One I B  Mutation: Two Phenotypes 564
crease in CD64 expression reached was lower than for the
healthy control and the mother (Fig. 3). Of note, the basal
expression level of CD64 was higher in father and son,
which may also partly have contributed to the reduced in-
crease in expression in response to IFN- . The addition of
100 IU/ml IFN-  to monocytes of father and son resulted
in CD64 up-regulation comparable to that found in control
monocytes stimulated with 10 U/ml IFN- . Thus, in con-
trast to what was found for TNF-  up-regulation in whole
blood, significant IFN- R signaling was detectable by mea-
suring CD64 expression, such that IFN-  responsiveness by
this assay was only moderately affected.
Oxidative Burst. All data shown above indicate that
TLR-induced signaling was impaired in the patient and his
father. To investigate whether the defect was upstream of
NF- B activation or at the level of NF- B itself, we mea-
sured the oxidative burst in formyl-methionyl-leucyl-
phenylalanine–stimulated PMNs primed with either LPS or
TNF- . Only the first steps in the LPS and TNF-  signal
transduction cascade are required to generate this response
(16–18), and mutations at the level of the NF- B complex
itself are not expected to affect the oxidative burst. In
healthy controls, the oxidative burst was enhanced 4.9- and
5.6-fold after priming with LPS and TNF- , respectively.
In the father, an enhanced oxidative burst was also ob-
served upon LPS or TNF-  priming (2.2- and 2.8-fold, re-
spectively), indicating that the defect was further down-
stream in the signal transduction cascade. PMNs of the
child could not be tested.
Translocation of NF- B to the Nucleus. Because all data
pointed to a defect at the level of the NF- B complex it-
self, we next studied p65 translocation to the nucleus in
monocyte-derived macrophages stimulated with LPS. In
control cells,  90% of all monocytes displayed clear nu-
clear p65 staining after stimulation with LPS. In the child,
p65 translocation was very inefficient (Fig. 4, A and B).
First, fewer cells displayed nuclear staining. Second, the in-
tensity of the nuclear staining was much lower in cells that
did show translocation (scored as intermediate transloca-
tion). When macrophages of his father were tested, p65
translocation was also reduced, albeit to a lesser degree than
in his son (Fig. 4 C). TNF-  stimulation was only used in
the father and this stimulus also appeared to result in a
lower level of p65 translocation (Fig. 4 D).
I B  Mutation in Both Patients. Based on our clinical
and functional data, and the phenotype of mice deleted in
various NF- B signaling components, genes encoding
IKK1, IKK2, and I B were the most likely candidates to
investigate. During our investigations, Courtois et al. (13)
published an IKBA mutation in a child with a clinical phe-
notype highly similar to that of our patient. Therefore, the
sequence of IKBA was determined and a heterozygous
G94T mutation was identified in both father and son re-
sulting in a serine to isoleucine substitution at position 32.
Serine 32 is one of the two serines that are phosphorylated
by the IKK complex upon stimulation. After its phosphor-
ylation, I B  is ubiquitinated and targeted to the protea-
some for breakdown, allowing NF- B translocation to the
nucleus. The heterozygosity of the mutation in both pa-
tients explains the residual activity found in our assays.
The paternal grandmother, three siblings of the father, and
the sibling and mother of the affected child did not display
this mutation. The father, his three siblings, and the
mother of the child were also heterozygous for a silent
C/T polymorphism at position 80, whereas the child was
homozygous for C at this position. The paternal grand-
mother of the child was homozygous for a C at position
80, indicating that it is likely that the mutation appeared
de novo in her son (on his maternal allele) and was not
Figure 3. IFN-  responsiveness of
monocytes. PBMCs of a healthy
control, the mother, the child, and
the father were incubated for 18 h
with increasing amounts of IFN- ,
and CD64 expression on CD14 
monocytes was measured by FACS
analysis. Data are expressed as the ra-
tio of median fluorescence of cells
cultured in the presence of IFN- 
over cells cultured in the absence of
IFN- . The median fluorescence of
unstimulated monocytes of the
healthy control, the mother, the son,
and the father was 66, 66, 145, and
90, respectively.
Figure 4. NF- B translocation in monocyte-derived macrophages.
Monocyte-derived macrophages were incubated with 1,000 ng/ml LPS
(A, B, and C) or 200 U/ml TNF-  (D) for 45 min, and p65 translocation
to the nucleus was analyzed (reference 14). Cells were stained with a p65-
specific antibody, after which a Rhodamine RedX–conjugated goat anti–
rabbit antibody was added. Nuclei were stained with DAPI and coverslips
were analyzed by fluorescence microscopy (B). Translocation of p65 to
the nucleus was scored by enumerating the number of cells that had no
nuclear staining ( ), cells that displayed intermediate nuclear staining
( ), or cells that displayed bright nuclear staining ( ).Janssen et al. 565
passed on by the grandfather, who was not available for
genetic testing.
Difference in Phenotype of Father and Son. Both patients
showed the same mutation in I B . However, there is a
striking difference between the disease severity of the fa-
ther and his son. All functional data indicated that cell-
mediated immune responses in the child, especially the T
cell function, are more severely affected than in his father.
One explanation for this difference could be that the resid-
ual NF- B–mediated transcription in the father is higher
than in his son. Several I B  promoter polymorphisms that
could account for this difference have been described and
some of them appear to be associated with inflammation
(15, 19). Because the mutation leads to the disappearance
of a restriction site, it was possible to compare the expres-
sion of the healthy allele and the mutated allele. RNA was
isolated from whole blood and used to generate cDNA.
PCR was performed to amplify the 5  part of the IKBA
gene and the product was digested with MspAI. RNA iso-
lated from blood samples taken with a 1-mo interval
showed that in the child’s whole blood, the wild-type al-
lele and the mutant allele are expressed at an equal level. In
the father, however, expression of the wild-type allele was
higher than the mutant allele (Fig. 5 A and Table III). For
comparison, the presence of the wild-type and mutant al-
lele was also analyzed in genomic DNA. Both in the father
and in the child the data obtained when genomic DNA
was analyzed were similar to those found in the mRNA,
indicating that in the father we are not dealing with a ma-
jor difference in expression level of the two alleles, but
with a mixed cell population.
Mosaicism in the Father. To ascertain whether we were
indeed dealing with mosaicism, genomic DNA of various
cell types of father and son were analyzed for the presence
of the mutation. In the child, all cell types tested displayed
the presence of equal amounts of wild-type and mutant al-
lele (Table III). When whole blood, PMN, monocytes,
buccalswab, and fibroblasts of the father were tested, it ap-
peared that in all these cell types there was more wild-type
allele than mutant allele present (Table III). Interestingly,
the T and B cells of the father almost exclusively displayed
Figure 5.  (A) Expression of wild-type versus mutated allele in whole
blood, T cells, and monocytes. mRNA was isolated, cDNA was gener-
ated, and exon 1 of I B was amplified by PCR. The PCR product was
digested with MspA1, which only digests the wild-type allele. (B) Pres-
ence of wild-type versus mutated allele in monocytes, CD45RA, and
CD45 RO cells of father and child. Genomic DNA was isolated from se-
lected cell populations and exon 1 of I B was amplified by PCR. The
PCR product was digested with MspA1, which only digests the wild-
type allele. Note that the size of the bands is different when DNA or
RNA is used as a template for PCR.
Table III. Determination of the Ratio of Wild-type/Mutant Allele or Polymorphic/Nonpolymorphic Allele
Father Son
Wild-type/mutantb
(genomic DNA)
Wild-type/mutant
(mRNA)
Polymorphic/nonpolymorphicc
(genomic DNA)
Wild-type/mutant
(genomic DNA)
Wild-type/mutant
(mRNA)
Buccalswab (1)a 3.60   0.94 ND 0.58   0.41 ND ND
Fibroblasts (1) 3.93   0.42 4.12   0.16 1.09   0.05 0.83   0.22 1.58   0.08
Whole blood (3) 5.65   0.94 7.66   1.76 0.56   0.13 0.98   0.03 1.11   0.05
PMN (2) 3.99   0.2 6.72   1.60 0.57   0.24 1.03   0.17 1.29   0.01
Monocytes (2) 3.93   0.1 9.03   2.45 1.07   0.05 1.17   0.12 ND
T cells (3) ND 41.1   12.4 ND ND 1.39   0.18
CD45RA 9.89   0.31 ND 1.16   0.07 1.19   0.10 ND
CD45RO 29.8   0.92 ND  1.20   0.06 1.85   0.26 ND
B cells ND 24.00   7.5 ND ND 1.98   0.08
aData were obtained from (n) independent cell samples. Each sample was used at least twice for PCR, digestion, and quantification.
bRatio of wild-type over mutant allele was determined using MspAI, which only digests the wild-type allele. Ratios were corrected using an exper-
imentally determined correction factor, as described in Materials and Methods.
cRatio of polymorphic over nonpolymorphic allele was determined using FokI, which only digests the polymorphic allele. Ratios were corrected
using an experimentally determined correction factor, as described in Materials and Methods.One I B  Mutation: Two Phenotypes 566
the wild-type allele. Because the father also had a silent
polymorphism upstream of the mutation, the presence of
this polymorphic allele was semiquantified. In the father, all
cell types tested displayed equal amounts of the polymor-
phic allele and the nonpolymorphic allele, indicating that
we are indeed dealing with mosaicism.
Selection of Wild-type Cells in the T and B Cell Compart-
ment. All the data presented above point to mosaicism,
hence the presence of a mixed cell population in the father.
In T and B cells of the father, however, only the wild-type
allele is present, suggesting that there is selection of wild-
type cells in the T and B cell compartment. In murine
models, it has been shown that memory T cell formation
is dependent on NF- B activation. Therefore, naive
CD45RA and antigen-experienced CD45RO cells were
isolated from the father, and the presence of the wild-type
and mutant allele was determined. CD45RA cells clearly
display the mutant allele, whereas CD45RO cells only dis-
play the wild-type allele (Fig. 5 B), indicating that in the fa-
ther there is in vivo selection of wild-type cells in the T
cell compartment.
Discussion
In this paper, we have identified a father and a son with a
genetic mutation in I B  replacing Ser 32, which is one of
the two serines that are phosphorylated by the IKK com-
plex upon stimulation. The signs and symptoms of the
child are compatible with a mutation at this critical site,
given the pivotal role of I B  in signal transduction. He
suffered from several severe infections in the first 6 mo of
life and because of a hyper IgM-like syndrome, he received
IgG supplementation and antibiotic prophylaxis. He has a
persistent lymphocytosis of T cells that are mainly of a na-
ive phenotype. The latter observation is consistent with the
observations that NF- B–mediated signal transduction is
crucial for the development of mature T cells (20). During
follow-up, typical clinical features of ectodermal dysplasia
became increasingly evident. The same mutation was re-
cently identified in a French patient with clinical symptoms
almost identical to those of our patient (13). In contrast, the
father of our patient, who has the same mutation but ex-
hibits a complex mosaicism, does not display any of these
symptoms. About 2 yr after discontinuation of steroid
treatment for JIA, he experienced a recurrent invasive S.
typhimurium infection. Finally, and after prolonged antibi-
otic treatment, he did not go through any more episodes of
serious infection. This is the first report showing that the
same IkB  mutation, which strongly impairs NF- B–acti-
vated gene expression, can lead to two completely different
clinical phenotypes.
Courtois et al. (13) have shown that a patient with the
same mutation displayed severely impaired T cell function.
We found identical features in our patient. In addition, we
now show that monocyte function is also impaired. When
responses to various PAMPs were evaluated, the most re-
markable observation was that both father and son were
unable to produce IL-12p40. However, normal levels of
TNF-  and IL-1  were produced, and only the child dis-
played impaired IL-6 production. Because both father and
son are heterozygous for the mutation, there is residual
NF- B activation as shown by our p65 translocation data.
Due to the mosaicism in the father, the residual NF- B ac-
tivity in his mixed cell population is higher than that in his
son. From our data, it is clear that not all NF- B–mediated
responses are affected to the same extent. Apparently, the
dependence on NF- B for various responses is graded
where TNF-  and IL-1  production is unaffected when
NF- B activation is suboptimal, IL-6 production requires a
higher level of activation, and IL-12p40 production re-
quires optimal NF- B activation. However, we have to
take into account that TNF-  and IL-1  are released from
preformed stores (a membrane-associated store for TNF- 
and an intracellular store for IL-1 ). Therefore, the levels
of these cytokines measured in father and son might be
largely independent of new synthesis. For TNF- , we
found that the level measured 4 h after the addition of LPS
was similar to that found after 18 h (not depicted), which
suggests that new synthesis may well be much slower in pa-
tients, although further studies are required to establish this.
The observation that not all promoters containing an
NF- B site are directly accessible (21) underlines our ob-
servation. Intriguingly, the IL-12p40 promoter only be-
comes accessible for the transcription machinery after his-
tone modifications (22), which depend on activation of
MAP kinases (22), indicating that stronger signals are re-
quired for IL-12p40 production. From previous studies in
NEMO-deficient patients, it also became apparent that
only a subset of NF- B–activated responses was affected. In
some patients, only CD40L-induced activation was se-
verely hampered, whereas TLR4 activation by LPS re-
mained largely intact (9), whereas in other NEMO patients
LPS activation was hampered (23). More studies in patients
with mutations in PAMP-induced signal transduction may
contribute to further unravel this complex pathway.
Patients with defects in IL-12p40 or IL-12–induced sig-
nal transduction are susceptible to infections with intracellu-
lar pathogens like mycobacteria and Salmonella, and from a
recent evaluation of patient data, the latter one appears to be
especially prevalent in this patient group (24). Although we
cannot rule out that the Salmonella infection in the father
was related to long-term steroid treatment, it may instead be
a result of his inability to produce IL-12p40. A possible role
of the I B   mutation and the consequent inability of
monocytes to produce IL-12 in the pathogenesis and the
disease course of JIA in the father are currently unclear.
The second striking feature found in our patients was the
severely impaired IFN-  response in whole blood of both
father and son. This is consistent with the observations that
MyD88 knockout mice are unable to mount a full-blown
IFN-  response (25). Because the genes for IL-12p40 and
TNF-  are regulated by both NF- B and STAT1, one
could hypothesize that insufficient NF- B activation
would impair STAT1-mediated transactivation, a modelJanssen et al. 567
similar to the one proposed by Shi et al. (25). In addition, it
has been shown that NF- B activation leads to STAT1
phosphorylation on Ser727, which enhances its transcrip-
tional activity (26, 27). Shi et al. (25) also showed that
STAT1 phosphorylation on Tyr701 is normal in MyD88
knockout mice, indicating that impaired LPS responsive-
ness per se does not lead to reduced IFN-  responsiveness.
Consistent with this, our CD64 up-regulation assay, which
is an indirect way of measuring STAT1-activated gene ex-
pression, i.e., Tyr701 phosphorylation, showed that this
was only somewhat impaired in our patient. This could be
attributable to reduced Ser727 phosphorylation, although it
is important to point out that basal expression levels of
CD64 in father and son were enhanced as compared with
those found in controls, which may also have accounted for
the lower degree of up-regulation observed. Apparently
transactivation of TNF-  production is impaired in the pa-
tients, whereas direct activation of the IFN- –responsive
CD64 gene remains largely intact. This may still preclude
full activation of the macrophages’ antimicrobial mecha-
nisms and contribute to the infection susceptibility of the
patients. In addition, it may hamper Th1 cell development.
The discrepancy in phenotype between father and son
remains the most intriguing finding in this dominant nega-
tive genetic disease. Genetic analysis of the paternal grand-
mother revealed that the mutation arose de novo in the fa-
ther. This fits well with the observed mosaicism in the
father and suggests that the mutation arose early in embry-
onic development, leading to a mixture of wild-type and
mutant cells. Because the T and B cell compartment of the
father is almost exclusively composed of wild-type cells,
one has to hypothesize that during T and B cell develop-
ment or activation, these wild-type cells have a selective ad-
vantage over mutant cells. The observation that memory T
cell activation in mice is highly dependent on NF- B acti-
vation underscores this hypothesis. When naive, CD45RA
and activated CD45RO cells were analyzed, it appeared
that only naive cells display the mutant allele, indicating
that there is in vivo selection of wild-type cells in the T cell
compartment of the father. This is consistent with studies in
murine models where NF- B activation was shown to be
crucial for development of mature T cells (20).
We conclude that the same I B  mutation can not only
be found in patients with typical ectodermal dysplasia and
severe immunodeficiency affecting innate and adaptive im-
munity, but also in individuals that do not display any of
the typical features expected to be associated with this de-
fect. The attenuated clinical disease of the father is a result
of a complex mosaicism and selection of wild-type–
expressing cells in the T and B cell compartment. Because
the amount of residual NF- B activation in father and son
appears to determine the severity of disease, further studies
should focus on the evaluation of the NF- B activation
pathway in larger groups of patients that do not display the
typical features that are thought to be associated with de-
fects in this pathway. Although TLR-mediated NF- B ac-
tivation is thought to be crucial to combat infections, there
appears to be a high level of redundancy, even in this signal
transduction cascade.
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